spontaneous tumors in cell morphology (Irie 1971) , karyotype (Irie et al. 1970a) , intracellular virus particles and expression of surface antigens . Nishioka and his colleagues described a tumor associated antigen named MM antigen on transplantable mouse mammary tumors of C3H/He mice (Chang et al. 1972) . MM antigen was strongly immunogenic in syngeneic mammary tumor virus positive (MTV) mice, inducing production of anti-MM antibody, and consequently specific tumor resistance in the host. The specificity of MM antigen was found on allogeneic lymphocytes of a variety of inbred mouse strains, but not on lymphocytes of C3H/He mice (Chang et al. 1972 ). Because of the similarity of the strain distributions of MM antigen and Ly-8.2 described by Frelinger and Murphy (1976) , we examined the specificity of the MM antigen and found that it was identical with that of Ly-8.2 (Oshima, thesis, 1980) . Subsequently very similar, genetically linked lymphocyte antigens, Ly-6 (McKenzie et al. 1977 ), Ala-1 (Feeney and Hammerling 1976) and others, were discovered and these antigens are now classified as an Ly-6 antigen complex (Kimura et al. 1984) . Furthermore, Seth et al. (1982) demonstrated that MM antigen is identical to Ly-6.2 by using monoclonal antibody against MM46 ascitic mammary tumor cells of C3H/He origin.
Recently, much attention has been paid to the heterogeneity of tumor cells appearing during tumor progression in terms of their metastatic and invasive activities and their conversion to the ascitic form (Nowell 1976; Kerbel 1979; Fidler and Hart 1982) . Thus, it is of interest to know whether the expression of new surface antigens on transplantable ascitic mammary tumor cells is a primary event in carcinogenesis or a secondary result of conversion of solid tumors to the ascitic form.
In this paper, we describe the expression of alien histocompatibility antigens in addition to MM antigen on the surface of ascitic tumor cells and the expression of MM antigen on aneuploid tumor cells appearing during conversion of a spontaneous mammary carcinoma in a C3H/He mouse to the ascitic form. The relationship between the expressions of these two alloantigens is also discussed.
MATERIALS AND METHODS

Mice
The female mice of various strains used in this study were obtained from our breeding colonies with the exception of the following mice : female C3H/He mice, which were obtained from Shizuoka Experimental Animal Farm, Shizuoka, female C57BL/6 mice from Funabashi Farm, Chiba, and BALB/c mice of both sexes from the Institute of Medical Science, University of Tokyo. Tumors MM102 (Irie et al. 1970b ), MM46 (Irie 1971) , and FM3A/R (Irie et al. 1970a ) tumor cell lines derived from individual spontaneous mammary carcinomas in C3H/He mice were all MM antigen positive.
MM46 was a cell line established 604 days after 26 transplant generations of a spontaneous mammary tumor, SMC XXVI of a MTV+ C3H/He mouse described by Irie (1971) . Another ascitic mammary tumor cell line, MM48 also used in the study was MM antigen negative and derived from SMC XXIII of a MTV+ C3H/He mouse (Irie 1971) . A cell suspension of a primary spontaneous mammary carcinoma was prepared by mincing the tumor with scissors and homogenizing it with Eagle's minimum essential medium (EMEM ; Nissui Pharmaceutical Co., Tokyo) in a glass homogenizer.
Chromosome analysis
The karyotype of tumor cells was analyzed as described previously (Irie et al. 1970a ).
Antisera C3H/He (MTV) anti-MM46 antiserum was prepared as described previously by . C311/He anti-AKR thymus antiserum was prepared as described previously (Reif and Allen 1966) . Alloantisera C-4, D-23, D-32, D-31A-J and D-28 were oligospecific antisera against H-2.4, H-2.23, H-2.32, H-2.31, and H-2.28, respectively, all of which were generously supplied from the Transplantation Immunology Branch, NIAID, NIH, Bethesda, MD, USA.
Microcytotoxicity test
The complement-dependent microcytotoxicity test was performed by the method of Koi and Tachibana (1976) with a minor modification. Briefly, l,ul volumes of cell suspension (2 x 106/ml) in phosphate-buffered saline (PBS) were introduced into wells of a microtest plate (#3034; Falcon Labware, Oxanard, CA, USA) which were precoated with poly-Llysine (Sigma Chemical Co., St. Louis, MO, USA). The cells were allowed to settle for 10 min at room temperature, and then l pl of RPMI 1640 medium (GIBCO Laboratories, Grand Island, NY, USA) supplemented with 2% heat-inactivated fetal calf serum (FCS ; Flow Laboratories, Rockville, MD, USA) was added followed by 5,ul of serial dilutions of antiserum or control serum. The plate was incubated for 30 min at 3TC. Then each well was washed 3 times with the medium, and 5,al of diluted low toxic rabbit complement was added to each well. The plate was incubated for 20 min at 37°C, and then 10 pl of 0.64% trypan blue solution was introduced into each well. The plate was stood for 6 min at room temperature and then promptly washed 3 times by filling it, including the wells with PBS containing 0.2% gelatin, and removing the PBS by pipette. The cells in the wells were fixed with PBS containing 0.25% glutaraldehyde and the stained and unstained cells were counted under a microscope. The cytotoxic index was calculated as follows :
1
-(living cells in test well(%)/living cells in control well(%)) Absorption test
Antibody absorptions were performed by incubating various numbers of tumor cells or lymph node cells (LNC) with antisera at a given concentration for 1 hr in ice-water and then determining the residual antibody activity toward various target cells by the microcytotoxicity test.
RESULTS
Surface antigens expressed on MM46 tumor cells
For determining the specificities of a pooled C3H/He antiserum against MM46 ascitic tumor cells, the reactivity of the anti-MM46 antiserum with various target cells including allogeneic lymphocytes in connection with the Ly-6 antigen complex was determined. Fig. 1 shows the results of complement-dependent direct cytotoxicity tests. The strong reactivity of the antiserum with MM46 tumor cells and C57BL/10 (B10) LNC was consistent with the data reported previously for MM antigen (Chang et al. 1972 ) and Ly-6 antigen (Horton et al. 1978) but the strong reaction with BALB/c LNC and the weak reaction with MM antigen negative MM48 tumor cells indicated the presence of additional antibodies in the anti-MM46 antiserum against shared antigens expressed on these cells. No reaction with C311/He LNC was observed (data not shown).
After extensive absorption of the antiserum with MM48 tumor cells in vitro, no reactivity with MM48 tumor cells was detected, but the reactivities with MM46 tumor cells and BALB/c LNC were still retained (Fig. 2) . The reactivities with MM46 tumor cells and B 10 LNC were still retained after additional in vivo absorption of the MM48-preabsorbed antiserum by its i.p. injection into a BALB/c mouse, but no reactivity with BALB/c LNC remained after this treatment (Fig.  3) .
Antigenic specificity was also determined with C3H/He anti-AKR thymus antiserum. Both MM46 tumor cells and B 10 LNC were lysed in the presence of rabbit complement, but MM48 tumor cells and BALB/c LNC were not lysed (Fig.  4) . These findings were supported by the results of an antibody absorption test (data not shown). These results indicate that MM46 tumor cells have at least three different antigen specificities : one shared (cross-reactive or identical) with MM48 tumor cells, one shared with BALB/c LNC, and one shared with B10 LNC. It is reasonable to define MM antigen as a cross-reactive alloantigen that is expressed on B10 LNC, but not on MM48 tumor cells or BALB/c LNC. Cross-reactive antigen specificity on MM46 tumor cells
The fact that MM46 tumor cells show antigenic specificity that is crossreactive with that on the surface of BALB/c LNC was confirmed by an absorption test (Fig. 5) . To characterize the specificity of the cross-reactive antigen, we used B10 congenic resistant strains for the absorption test (Fig. 6) . Since all B10 congenic resistant strains have Ly-6 specificity that is cross-reactive with MM antigen, the involvement of the MM antigenic determinant in the assay could be avoided. When BALB/c LNC were used as targets, B10 and B 10.D2 as well as BALB/c LNC showed the capacity for absorption of antibody to BALB/c LNC, but B10.A LNC unexpectedly showed only a low capacity (Fig. 6) . The difference in the absorption capacities of these B10 congenic resistant strains, thus resides in their difference of H-2 haplotype. Table 1 shows the private and public specificities in H-2 haplotype of B 10 congenic resistant strains, together with those of C3H/He and BALB/c (Klein et al. 1983 ). B10.A has the genotype KkDc, and B10.D2/n has the genotype K'D'. Thus, it is clear that the change from Ka to Kk results in marked decrease in the absorption capacity.
The most common specificities of H-2 antigen between BALB/c (H-2') and 
B10 (H-2b) are the H-2.28 family. If MM46 tumor cells express alien H-2.28
public antigen specificity, anti-MM46 antiserum can react with alien lymph node cells, which express this specificity. Conversely, alien lymph node cells that do not express this specificity cannot absorb the cytotoxic activity of the antitumor antiserum toward BALB/c LNC. One of the B10 congenic resistant strains, B10. RIII (71NS) (H-2r) does not have this public specificity (Table 1 ). Fig. 7 shows that B10.RIII (71 NS) LNC had no absorption capacity for the cytotoxic antibody.
Expression of alien H-2 specificities on MM46 tumor cells
To ascertain the alien H-2 specificities on MM46 tumor cells, we used D-31A-J (Kd), C-4 (Dr'), and D-28 (H-2.28) alloantisera for cytotoxicity and absorption tests. We also compared the expressions of Kk and Dk antigens on MM46 tumor cells and other MM antigen positive and negative tumor cell lines. Table 2 (Fig. 8 ), but they were not lysed by D-28 antiserum plus rabbit complement in a cytotoxicity test (data not shown). Like H-2.28 negative C311/He LNC, MM48 tumor cells showed little absorption of the cytotoxic activity (Fig. 8) .
MM antigen expression on aneuploid tumor cells appearing during ascitic tumor cell conversion
Since established ascitic mammary tumor cell lines with the hypotetraploid karyotype of C311/He mouse origin express MM antigen on the cell surface, as Irie et al. (1970a) , we examined the expression of MM antigen and the karyotype of tumor cells at various stages during serial passage for conversion of a solid tumor to ascitic free tumor cells. Parts of a spontaneous mammary carcinoma and tumors grown after successive transplantations were homogenized, washed 5 or 10 times with EMEM and inoculated into the peritoneal cavity of C3H/He mice. The other parts were used for assay of MM antigen and chromosome analysis. Samples of 1 X log cells were used for absorption of anti-MM antiserum, since no antibody activity was absorbed by 1 X 108 spontaneous tumor cells. Samples of approximately 100 tumor cells were used for karyotyping. Representative results are shown in Table 3 . Most of the cells in transplanted tumors remained in the solid form with the diploid karyotype until the 9th transplant generation. But at the 7th and 9th generations, the numbers of diploid tumor cells decreased to 70-80% and coincidently weak absorption capacity of the tumor cells for anti-MM antibody appeared. At the 10th transplant generation, tumor cells were abruptly converted to the ascitic form and free tumor cells showed striking increase in chromosome number and in capacity for absorption of anti-MM antibody. At the 16th generation, the subpopulation of nearly diploid tumor cells increased in the ascites and concomitantly the absorption capacity of the whole tumor cell population for anti-MM antibody also decreased. When the major population of ascitic tumor cells that emerged in the first ascitic conversion was hyperdiploid, as in the MM48 ascitic tumor cell line, no 
DISCUSSION
As reported previously (Chang et al. 1972 ), we observed a tumor-associated MM antigen expressed on the surface of an ascitic mouse mammary tumor cell line, MM46. From the present results, the specificity of MM antigen appears to be identical or cross-reactive with that of Ly-6.2 antigen. Seto et al. (1982) prepared monoclonal antibody to MM antigen and demonstrated the identical specificity of MM antigen with that of Ly-6.2. At present, it is thought that Ly-6 consists of a gene family encoding a group of antigens closely associated with each other because of their distinct tissue distribution and appearance in cells in the activated state (Kimura et al. 1984) . We found that C3H/He antiserum against an MM antigen-positive tumor did not react with thymus or peripheral T cells of C57BL/ 6 mice, in contrast to the report of Chang et al. (1972) . Thus, it is probable that there are polymorphic MM antigens akin to the Ly-6 antigen complex. In analyses of the reactivities of C3H/He (MTV) anti-MM46 antiserum, we also observed the expression of alien H-2 antigenic specificities, H-2.31 and H-2.28, but not H-2.4 on the same tumor cells. H-2.31 represents the private specificity of the H-2Kd molecule, while H-2.4 represents the private specificity of the H-2Dd molecule. On the other hand, H-2.28 represents a public specificity shared among the molecules encoded by H-2K, H-2D, and H-2L loci in'the majority of original H-2 haplotypes of inbred laboratory mice, but no H-2 molecule of the H-2k haplotype bears this public specificity. On the contrary, all H-2 molecules determined independently by 3 distinct H-2 loci of the H-2d haplotype bear H-2.28 specificity. Thus the expression of H-2.28 specificity means that 11-2K' or H-2L d or both are present. This requires further investigation. Recently, a UV-induced fibrosarcoma 1591 of a C 3H mouse was reported to express two H-2-like molecules, one with the characteristics of both H-2Kk and H-2D' molecules and the other similar, but not identical to the H-2Ld molecule as judged by biochemical analyses using monoclonal antibodies Philipps et al. 1985) . 1591 fibrosarcoma cells are tetraploid, like MM46 and other MM antigen positive ascitic mammary tumor cells of C3H mouse origin.
Previously we observed a reciprocal relationship between the expressions of MM antigen and H-2k antigen on MM antigen positive tumor cell lines. MM antigen is expressed on the surface of hypotetraploid tumor cell lines, but not hyperdiploid tumor cell lines. We were interested to know whether expression of MM antigen appeared after the establishment of tumor cell lines. This study showed that this was not the case, but that the expression of MM antigen was closely associated with the appearance of hypotetraploid tumor cells irrespective of whether conversion to the ascitic form was complete. It is uncertain at present whether MM antigen and alien H-2 antigen appear simultaneously. But, we consistently observed a reciprocal relation between the expressions of MM antigen and H-2k antigen and the appearance of alien H-2 antigen on the MM antigen positive tumor cell lines tested, even though these tumor cell lines were derived from different tumors and established by different workers at different times. In this regard, it is noteworthy that recently we also observed reciprocal expressions of MM and H-2k antigen on many somatic hybrid clones obtained by cell fusion of spontaneous mammary carcinoma cells with L cells of C3H mouse origin (Masuko et al. 1983; Dei et al. 1986 ). Without exception, no MM antigen was detectable on hybrid cells showing full expression of H-2k antigen and vice versa. MM antigen expression was observed more often on cell fusion of tumor cells with L cells in the mitotic phase than with those in the interphase, though most tumor cells used appeared to be in the G1 phase. Furthermore, MM antigen positive cells maintained more total chromosomes and fewer marker chromosomes derived from L cells than MM antigen negative cells, suggesting that the particular changes of chromosomes, e.g., translocation and deletion, are closely associated with variation in the expression of these surface antigens. Therefore, the generation of MM antigen bearing ascites tumor cells may be due to a sequence of definite chromosomal aberrations in hypotetraploidy.
With regard to the mechanism of expression of alien histocompatibility and allelic Ly-6.2 antigen on tumors of Ly-6.1 positive C311/He mice, several models that have been presented to explain the polymorphism of the murine major histocompatibility complex may be applicable. These include a regulatory gene model (Bodmer 1973) , a gene conversion model (Pease et al. 1983; Weiss et al. 1983 ), and so on. As mentioned above, if there is a close association of variation in expression of 3 distinct surface antigens, some mechanism may regulate expression of these antigens as a whole. Further studies at molecular and genetic levels on the expressions and regulations of these antigens are needed to clarify these important problems.
